Pre-assay calcitonin test reagent for Roche immunoassay. - Taiwan Registration 9b1aac534321e72ed14c5d6986346a0a
Access comprehensive regulatory information for Pre-assay calcitonin test reagent for Roche immunoassay. in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 9b1aac534321e72ed14c5d6986346a0a and manufactured by ROCHE DIAGNOSTICS GMBH. The authorized representative in Taiwan is ROCHE DIAGNOSTICS LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product uses electrochemiluminescence immunoassay (ECLIA) with Elecsys 2010, cobas e 411, MODULAR ANALYTICS E170, coabs e 601, and cobas e 602 immunoassays to quantitatively detect procalcitonin (PCT) in human serum and plasma in vitro. This product (specification: 07301715190) uses electrochemiluminescence immunoassay (ECLIA) with cobas e 801 immunoassay to quantitatively detect procalcitonin (PCT) in human serum and plasma in vitro. This product (08828644190) uses electrochemiluminescence immunoassay (ECLIA) with cobas e 411, coabs e 601, and cobas e 602 immunoassays for the quantitative detection of procalcitonin (PCT) in human serum and plasma in vitro. This product (08828679190) uses electrochemiluminescence immunoassay (ECLIA) with cobas e 801 immunoassay to quantitatively detect procalcitonin (PCT) in human serum and plasma in vitro. The following blank models 08828679190 change the efficacy (new applicable models) are: This product uses electrochemiluminescence immunoassay (ECLIA) with cobas e 402 and cobas e 801 immunoassay to quantitatively detect procalcitonin (PCT) in human serum and plasma in vitro. The following blanks
C Immunology and microbiology
import
Dates and Status
Feb 27, 2009
Feb 27, 2029